Crossmark

Sodium-glucose cotransporter 2 inhibitors and cardiovascular events among patients with type 2 diabetes and low-to-normal body mass index: a nationwide cohort study

Crossref DOI link: https://doi.org/10.1186/s12933-024-02478-7

Published Online: 2024-10-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mori, Yuichiro

Komura, Toshiaki

Adomi, Motohiko

Yagi, Ryuichiro

Fukuma, Shingo

Kondo, Naoki

Yanagita, Motoko

Duru, O. Kenrik

Tuttle, Katherine R.

Inoue, Kosuke
Funding

Funding for this research was provided by:

Japan Health Insurance Association
License Information

Text and Data Mining valid from 2024-10-22

Version of Record valid from 2024-10-22
More Information

Article History

Received: 28 August 2024

Accepted: 16 October 2024

First Online: 22 October 2024

Declarations

:

: All authors have completed the ICMJE uniform disclosure format (available on request from the corresponding author).

Document is current

Any future updates will be listed below